Gemmer Asset Management’s Outset Medical OM Stock Holding History

Gemmer Asset Management’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4	Closed	-$3K	–	1388
2021 Q2	$3K	Buy	+4	New	+$3.06K	﹤0.01%	1312

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCP

D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Gemmer Asset Management's OM Position: Q3 2021 in Review

Gemmer Asset Management sold out of Outset Medical (OM) in Q3 2021, closing a stake of 4 shares — an estimated $3K sold.

Gemmer Asset Management first reported a position in OM in Q2 2021 and held it in 1 quarter. The position peaked at $3K in Q2 2021. 142 funds tracked by Wall St. Rank hold OM as of Q3 2021.

Gemmer Asset Management reported no remaining Outset Medical position as of Q3 2021 after selling out during the quarter.
Gemmer Asset Management sold 4 Outset Medical shares in Q3 2021, an estimated $3K.
Gemmer Asset Management first reported a position in Outset Medical in Q2 2021 and held it in 1 quarter.
Gemmer Asset Management's Outset Medical position peaked at $3K in Q2 2021.
142 funds tracked by Wall St. Rank held Outset Medical as of Q3 2021.

Based on Gemmer Asset Management's 13F filing for Q3 2021, filed 19 Oct 2021.